767 related articles for article (PubMed ID: 12468591)
1. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
Setchell KD; Brown NM; Lydeking-Olsen E
J Nutr; 2002 Dec; 132(12):3577-84. PubMed ID: 12468591
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
Yuan JP; Wang JH; Liu X
Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of soy isoflavone-glycosides in laying hens: intestinal absorption and preferential accumulation into egg yolk of equol, a more estrogenic metabolite of daidzein.
Saitoh S; Sato T; Harada H; Matsuda T
Biochim Biophys Acta; 2004 Sep; 1674(2):122-30. PubMed ID: 15374616
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
[TBL] [Abstract][Full Text] [Related]
5. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
[TBL] [Abstract][Full Text] [Related]
6. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
7. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
[TBL] [Abstract][Full Text] [Related]
8. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
McCarty MF
Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
[TBL] [Abstract][Full Text] [Related]
9. Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets.
Muñoz Y; Garrido A; Valladares L
Thromb Res; 2009 Mar; 123(5):740-4. PubMed ID: 18786699
[TBL] [Abstract][Full Text] [Related]
10. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Atkinson C; Frankenfeld CL; Lampe JW
Exp Biol Med (Maywood); 2005 Mar; 230(3):155-70. PubMed ID: 15734719
[TBL] [Abstract][Full Text] [Related]
11. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
12. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes.
Liew R; Williams JK; Collins P; MacLeod KT
J Pharmacol Exp Ther; 2003 Mar; 304(3):985-93. PubMed ID: 12604673
[TBL] [Abstract][Full Text] [Related]
13. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
[TBL] [Abstract][Full Text] [Related]
14. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life.
Setchell KD; Zimmer-Nechemias L; Cai J; Heubi JE
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1453S-1461S. PubMed ID: 9848516
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
Liu ZM; Ho SC; Woo J; Chen YM; Wong C
Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
[TBL] [Abstract][Full Text] [Related]
16. Research protocol: effect of natural S-equol on blood pressure and vascular function--a six-month randomized controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension.
Liu ZM; Ho SC; Chen YM; Xie YJ; Huang ZG; Ling WH
BMC Complement Altern Med; 2016 Mar; 16():89. PubMed ID: 26928904
[TBL] [Abstract][Full Text] [Related]
17. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
18. Bioconversion of Isoflavones into Bioactive Equol: State of the Art.
Lopes DB; de Avila ARA; de Queiros LD; Macedo JA; Macedo GA
Recent Pat Food Nutr Agric; 2016; 8(2):91-98. PubMed ID: 28590886
[TBL] [Abstract][Full Text] [Related]
19. Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans.
Zhang X; Veliky CV; Birru RL; Barinas-Mitchell E; Magnani JW; Sekikawa A
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835997
[TBL] [Abstract][Full Text] [Related]
20. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
